Related Experiment Video
Updated: Aug 5, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Diagnosis and management of glaucoma
1Department of Ophthalmology, Catholic Medical Center of Brooklyn, New York.
Clinical Symposia (Summit, N.J. : 1957)
|January 1, 1991
Summary
This revision of the glaucoma clinical symposia reflects public health impacts and advances in diagnosis and treatment. New illustrations enhance understanding of this vision-impairing eye disease.
Area of Science:
- Ophthalmology
- Public Health
Background:
- The seminal 1976 Clinical Symposia on glaucoma, updated in 1981, provided foundational knowledge.
- Significant advancements in glaucoma diagnosis and treatment necessitate a current overview.
- The public health burden of glaucoma underscores the need for updated clinical guidance.
Purpose of the Study:
- To present a comprehensively revised edition of the Clinical Symposia on glaucoma.
- To incorporate recent breakthroughs in the diagnosis and management of glaucoma.
- To provide an updated, illustrated resource for clinicians and researchers.
Main Methods:
- Complete rewriting of the existing text by leading experts.
- Inclusion of entirely new, high-quality illustrations by a renowned ophthalmologist.
- Integration of the latest research findings and clinical best practices.
Main Results:
- A fully updated and expanded text reflecting the current state of glaucoma care.
- Enhanced visual aids for improved understanding of complex glaucomatous changes.
- A comprehensive resource addressing the evolving landscape of glaucoma management.
Conclusions:
- The revised symposia offer a vital update on glaucoma, crucial for addressing its public health impact.
- This new edition serves as an essential reference for contemporary diagnosis and treatment strategies.
- The integration of new research and illustrations ensures relevance for current clinical practice.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...